🇺🇸 FDA

Company profile · Sponsor

LIXTE

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT · NYSE biotech BOCA RATON, FL, USA
Pipeline
3
Drugs
0
Patents
8

Quick answer

LIXTE (LIXT) is a biotech company. headquartered in BOCA RATON, FL, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker LIXT
Exchange NYSE
Company type biotech
Headquarters BOCA RATON, FL, USA
SEC CIK 0001335105

Pipeline (3)

Search pipeline →

  1. Dostarlimab

    LIXTE

    Ovarian Clear Cell Carcinoma

    phase 2 small molecule active

    1 trial

  2. LB-100

    LIXTE

    Myelodysplastic Syndromes

    phase 2 small molecule active

    1 trial

  3. LB-100 for Injection

    LIXTE

    Tumors

    phase 1 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12343342

    Methods for treating soft tissue sarcoma

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11931354

    Formulations of oxabicycloheptanes and oxabicycloheptenes

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11866444

    Oxabicycloheptane prodrugs

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11236102

    Oxabicycloheptane prodrugs

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10668062

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10618908

    Oxabicycloheptane prodrugs

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10532050

    Formulations of oxabicycloheptanes and oxabicycloheptenes

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10434100

    Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is LIXTE?

LIXTE (LIXT) is a biotech company. headquartered in BOCA RATON, FL, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does LIXTE sponsor?

We track 3 ClinicalTrials.gov-linked programs for LIXTE, including Dostarlimab and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does LIXTE company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.